Skip to main content
Log in

Immunohistochemical Features of O6-Methylguanine-DNA Methyltransferase Expression during Ovarian Endometriosis

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

A comparative immunohistochemical study for the expression of O6-methylguanine-DNA methyltransferase (MGMT) was performed in tissues of the eutopic endometrium and ovarian endometriosis. The highest level of MGMT expression in eutopic endometrial tissue was observed in epitheliocyte nuclei during the proliferative phase. In regions of endometriosis the expression of MGMT in epitheliocyte nuclei was shown to increase during stages I and II, but decreased in stages III and IV. The progression of endometriosis was accompanied by a gradual increase of study parameters in the nuclei and cytoplasm of stromal cells. These changes reflect the impairment of DNA reparation, which probably serves as a stage in the development and progression of endometriosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adamyan LV, Kulakov VI, Andreeva EN. Endometriosis. Guideline for Physicians. Moscow, 2006. Russian.

  2. Kogan YA, Askolskaya SI, Sagindykova RR, Fayzullina NM, Asaturova AV, Unanjan AL. Impaired expression of the proteins MGMT and ezrin in endometrial hyperplasia, endometrial intraepithelial neoplasia, and low-grade endometrioid adenocarcinoma in perimenopausal women. Akush. Gin. 2015(2):44-48. Russian.

  3. Shchegolev AI, Bykov AG, Tumanova UN, Pavlovich SV. Endometriosis and the development of tumors. Akush. Gin. 2016(11):49-56. Russian.

  4. Benagiano G, Brosens I. History of adenomyosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2006;20(4):449-463.

    Article  PubMed  Google Scholar 

  5. Brell M, Tortosa A, Verger E, Gil JM, Viñolas N, Villá S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin. Cancer Res. 2005;11(14):5167-5174.

    Article  CAS  PubMed  Google Scholar 

  6. De Vita VT, Hellman S, Rosenberg S. Cancer: Principles & Practice of Oncology. Philadelphia, 2005. P. 408-409.

  7. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789-1799.

    Article  PubMed  Google Scholar 

  8. Kuester D, El-Rifai W, Peng D, Ruemmele P, Kroeckel I, Peters B, Moskaluk CA, Stolte M, Mönkemüller K, Meyer F, Schulz HU, Hartmann A, Roessner A, Schneider-Stock R. Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett’s esophagus. Cancer Lett. 2009;275(1):117-126.

    Article  CAS  PubMed  Google Scholar 

  9. Lee KE. Immunohistochemical Assessment of O6-methylguanine-DNA methyltransferase (MGMT) and its relationship with p53 expression in endometrial cancers. J. Cancer Prev. 2013;18(4):351-354.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nakagawa T, Ido K, Sakuma T, Takeuchi H, Sato K, Kubota T. Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas. Neuropathology. 2008;29(4):379-388.

    Article  PubMed  Google Scholar 

  11. Ouadid-Ahidouch H, Rodat-Despoix L, Matifat F, Morin G, Ahidouch A. DNA methylation of channel related genes in cancers. Biochim. Biophys. Acta. 2015;1848(10, Pt B):2621-2628.

    Article  CAS  PubMed  Google Scholar 

  12. Preuss I, Haas S, Eichhorn U, Eberhagen I, Kaufmann M, Beck T, Eibl RH, Dall P, Bauknecht T, Hengstler J, Wittig BM, Dippold W, Kaina B. Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Cancer Detect. Prev. 1996;20(2):130-136.

    CAS  PubMed  Google Scholar 

  13. Rimel BJ, Huettner P, Powell MA, Mutch DG, Goodfellow PJ. Absence of MGMT promoter methylation in endometrial cancer. Gynecol. Oncol. 2009;112(1):224-228.

    Article  CAS  PubMed  Google Scholar 

  14. Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas. Int. J. Oncol. 2008;33(3):469-475.

    CAS  PubMed  Google Scholar 

  15. Zhang L, Zeng J, Zeng Z, Wang F, Wang D, Chen C, Li C, An X, Xu R, Huang P, Ba Y, Li Y. MGMT in colorectal cancer: a promising component of personalized treatment. Tumour Biol. 2016;37(8):11 443-11 456.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. Shchegolev.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 9, pp. 372-376, September, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shchegolev, A.I., Bykov, A.G., Faizullina, N.M. et al. Immunohistochemical Features of O6-Methylguanine-DNA Methyltransferase Expression during Ovarian Endometriosis. Bull Exp Biol Med 164, 386–389 (2018). https://doi.org/10.1007/s10517-018-3995-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-3995-z

Key Words

Navigation